References
- Agarwal R, Dhooria S, Sehgal, IS, et al. A randomized trial of itraconazole versus prednisolone in acute-stage ABPA complicating asthma. CHEST. 2018;153(3):656–664. doi:10.1016/j.chest.2018.01.005
- Resp&sleep JC #rsjc [respandsleepjc]. #rsjc In terms of primary composite endpoint… was it validated before? @riteshpgi - can you give us the reference if validated?. January 18, 2018, 2147 h EDT. Tweet. https://twitter.com/respandsleepjc/status/954183505214394370
- Anand A. [thelungdr]. #rsjc @riteshpgi - how did you control for crossover in India and cointervention (incl NHP and aruveydic medications). January 18, 2018, 2158 h EDT. Tweet. https://twitter.com/thelungdr/status/954186224738226177
- Manji S. [shaz_ramji]. @respandsleepjc But this means they have lost randomization! They should have kept the patients in there group. Especially an issue in a sample size study. January 18, 2018, 2100 h EDT. Tweet. https://twitter.com/shaz_ramji/status/954171635283709952
- Agarwal R. [riteshpgi]. @respandsleepjc The important conclusion is that ITCZ is effective as monotherapy in a large number of patients. So, if you have a patient with high-risk for steroid (diabetes, obesity, severe osteoporosis) complications, you could start ITCZ upfront. January 18, 2018, 2148 h EDT. Tweet. https://twitter.com/riteshpgi/status/954183734202327041